2013
DOI: 10.1016/j.jconrel.2012.12.014
|View full text |Cite
|
Sign up to set email alerts
|

How cationic lipids transfer nucleic acids into cells and across cellular membranes: Recent advances

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
131
0
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 172 publications
(134 citation statements)
references
References 153 publications
2
131
0
1
Order By: Relevance
“…Positively charged nanoparticles have a high affinity to negatively charged proteoglycans expressed on the surface of most cells, resulting in more efficient adsorptive endocytosis, compared with neutral and negatively charged nanoparticles. Of note, heparan sulfate proteoglycans, comprise transmembrane proteins termed syndecans, are considered major binding sites for cationic delivery vehicles [78]. However, such cationic nanoparticles are not able to take advantage of systemic administration due to non-specific interactions with negatively charged blood components before reaching target cells.…”
Section: Design Criteria To Overcome Intracellular Barriersmentioning
confidence: 99%
“…Positively charged nanoparticles have a high affinity to negatively charged proteoglycans expressed on the surface of most cells, resulting in more efficient adsorptive endocytosis, compared with neutral and negatively charged nanoparticles. Of note, heparan sulfate proteoglycans, comprise transmembrane proteins termed syndecans, are considered major binding sites for cationic delivery vehicles [78]. However, such cationic nanoparticles are not able to take advantage of systemic administration due to non-specific interactions with negatively charged blood components before reaching target cells.…”
Section: Design Criteria To Overcome Intracellular Barriersmentioning
confidence: 99%
“…Since the structure of the cationic lipid-DNA assemblies affect their interactions with cells (Allen and Cullis 2013;ur Rehman et al 2013;Dan and Danino 2014), the structural effects described for DODAB and diC14-amidine should be taken in account when planning biotechnological applications, such as delivery systems.…”
Section: Dnamentioning
confidence: 99%
“…Establishment of their safety then led to cationic membranes being then employed as carriers of proteins and nucleic acids to eukaryotic cells (Zelphati et al 2001;ur Rehman et al 2013). This technical development enabled the study of gene function, silencing and therapy (Caracciolo and Amenitsch 2012) and stimulated the development of dozens of lipids with different cationic headgroups and hydrophobic moieties (ur Rehman et al 2013;Junquera and Aicart 2016;Majzoub et al 2016). In this review we focus on membranes formed by two cationic lipids: dioctadecyldimethylammonium bromide (DODAB) and diC14-amidine (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…The strategy explored involves the incorporation of cationic lipid within the surfactant layer surrounding the nanoemulsion. Cationic nanoparticles are generally more effectively taken up by cells owing to the electrostatic interaction between nanoparticles and the negatively charged glycoproteins abundant on cell membranes [20]. Since ICG-loaded nanoemulsions exhibit a negative surface charge owing to the anionic property of ICG [16], it was assumed that incorporation of a cationic lipid would increase the cellular uptake of nanoemulsions by switching the surface charge to a positive value.…”
Section: Introductionmentioning
confidence: 99%